332 related articles for article (PubMed ID: 16877411)
1. Differential effects of costimulatory pathway modulation on corneal allograft survival.
Watson MP; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3417-22. PubMed ID: 16877411
[TBL] [Abstract][Full Text] [Related]
2. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
3. ICOS/B7RP-1 interference in mouse kidney transplantation.
Lutz J; Lu R; Strobl M; Huang H; Deng M; Wang M; Ouyang N; Heemann U
Transplantation; 2007 Jul; 84(2):223-30. PubMed ID: 17667814
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
[TBL] [Abstract][Full Text] [Related]
5. Blockade of CD40-CD154 costimulatory pathway promotes survival of allogeneic corneal transplants.
Qian Y; Boisgerault F; Benichou G; Dana MR
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):987-94. PubMed ID: 11274076
[TBL] [Abstract][Full Text] [Related]
6. Modulation of costimulation by CD28 and CD154 alters the kinetics and cellular characteristics of corneal allograft rejection.
Ardjomand N; McAlister JC; Rogers NJ; Tan PH; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2003 Sep; 44(9):3899-905. PubMed ID: 12939307
[TBL] [Abstract][Full Text] [Related]
7. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
8. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance.
Wang L; Han R; Hancock WW
Eur J Immunol; 2007 Oct; 37(10):2983-90. PubMed ID: 17899549
[TBL] [Abstract][Full Text] [Related]
10. Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.
Ozkaynak E; Gao W; Shemmeri N; Wang C; Gutierrez-Ramos JC; Amaral J; Qin S; Rottman JB; Coyle AJ; Hancock WW
Nat Immunol; 2001 Jul; 2(7):591-6. PubMed ID: 11429542
[TBL] [Abstract][Full Text] [Related]
11. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival.
Dudler J; Li J; Pagnotta M; Pascual M; von Segesser LK; Vassalli G
Transplantation; 2006 Dec; 82(12):1733-7. PubMed ID: 17198268
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the OX40 ligand prolongs corneal allograft survival.
Hattori T; Usui Y; Okunuki Y; Sonoda Y; Usui M; Takada E; Mizuguchi J; Yagita H; Okumura K; Akiba H; Takeuchi M
Eur J Immunol; 2007 Dec; 37(12):3597-604. PubMed ID: 18022861
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cells play no essential role in acute rejection of orthotopic corneal allografts in mice.
Yamada J; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):386-92. PubMed ID: 11157871
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
Transplantation; 2005 Jul; 80(2):255-63. PubMed ID: 16041272
[TBL] [Abstract][Full Text] [Related]
15. Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway.
Kosuge H; Suzuki J; Gotoh R; Koga N; Ito H; Isobe M; Inobe M; Uede T
Transplantation; 2003 Apr; 75(8):1374-9. PubMed ID: 12717233
[TBL] [Abstract][Full Text] [Related]
16. Effect of alloantibodies on corneal allograft survival.
Hegde S; Mellon JK; Hargrave SL; Niederkorn JY
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1012-8. PubMed ID: 11923241
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses.
Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK
Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712
[TBL] [Abstract][Full Text] [Related]
18. Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation.
Guo L; Li XK; Enosawa S; Funeshima N; Suzuki S; Kimura H; Sugawara Y; Tezuka K; Makuuchi M
Liver Transpl; 2004 Jun; 10(6):743-7. PubMed ID: 15162468
[TBL] [Abstract][Full Text] [Related]
19. Transferable cardiac allograft acceptance induced by transfusion of donor B cells with impaired inducible costimulator/B7h allorecognition.
Du JF; Wang C; Wang WZ; Li MB; Liang HL; Guan WX
Transplant Proc; 2009 Jun; 41(5):1840-3. PubMed ID: 19545740
[TBL] [Abstract][Full Text] [Related]
20. Local gene transfer to modulate rat corneal allograft rejection.
Jessup CF; Brereton HM; Sykes PJ; Thiel MA; Coster DJ; Williams KA
Invest Ophthalmol Vis Sci; 2005 May; 46(5):1675-81. PubMed ID: 15851568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
